Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Small Cell Lung Cancer (SCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06496048
What this trial is testing

Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC

Who this might be right for
Relapsed Small Cell Lung Cancer
Luye Pharma Group Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT00182689
What this trial is testing

Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
National Cancer Institute (NCI) 89
Testing effectiveness (Phase 2)Study completedNCT00855894
What this trial is testing

The Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 41
Testing effectiveness (Phase 2)UnknownNCT03732846
What this trial is testing

Anlotinib in Treatment of Recurrent Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 43
Large-scale testing (Phase 3)Looking for participantsNCT06247605
What this trial is testing

A Phase IIII Study of AL8326 in Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Advenchen Laboratories Nanjing Ltd. 243
Large-scale testing (Phase 3)UnknownNCT02643407
What this trial is testing

Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Guangdong Association of Clinical Trials 488
Not applicableWithdrawnNCT01325753
What this trial is testing

Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body

Who this might be right for
Advanced Malignant MesotheliomaExtensive Stage Small Cell Lung CancerLung Metastases+4 more
Wake Forest University Health Sciences
Early research (Phase 1)Study completedNCT00933777
What this trial is testing

SORAVE - Sorafenib and Everolimus in Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol SpecificNon-Small Cell Lung Cancer
University of Cologne 36
Not applicableStudy completedNCT01999881
What this trial is testing

Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients

Who this might be right for
Extensive Stage Small Cell Lung CancerHealthy, no Evidence of DiseaseLimited Stage Small Cell Lung Cancer+9 more
University of Wisconsin, Madison 21
Testing effectiveness (Phase 2)Ended earlyNCT03879798
What this trial is testing

DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Looking for participantsNCT06780137
What this trial is testing

Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Who this might be right for
Small Cell Lung Cancer
Merck Sharp & Dohme LLC 327
Not applicableStudy completedNCT04634630
What this trial is testing

The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung

Who this might be right for
Lung Cancer, Nonsmall CellRelapse/RecurrenceCSC
Beatrice Aramini 35
Early research (Phase 1)Study completedNCT06799286
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bristol-Myers Squibb 10
Testing effectiveness (Phase 2)Ended earlyNCT02403895
What this trial is testing

AZD2014 and Weekly Paclitaxel in Squamous NSCLC

Who this might be right for
Squamous Non Small Cell Lung Cancer
AstraZeneca 11
Early research (Phase 1)Looking for participantsNCT06931626
What this trial is testing

Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Nerviano Medical Sciences 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT06581380
What this trial is testing

JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
JenKem Technology Co., Ltd. 394
Not applicableNot Yet RecruitingNCT06848426
What this trial is testing

Xingbai Ji Formula Combined with Chemotherapy and Sintilimab in Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer: a Clinical Trial

Who this might be right for
Non-Small Cell Lung CancerNon-small Cell Lung Cancer RecurrentNon-small Cell Lung Cancer Stage IIIB+2 more
Jiangxi Provincial People's Hopital 100
Testing effectiveness (Phase 2)Study completedNCT00138203
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 16
Early research (Phase 1)Looking for participantsNCT07488923
What this trial is testing

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

Who this might be right for
Small Cell Lung Cancer (SCLC )Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)Gastroenteropancreatic NEC (GEP NEC)+1 more
Moonlight Bio, Inc 110
Early research (Phase 1)Study completedNCT03216343
What this trial is testing

Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Chipscreen Biosciences, Ltd. 48
Next Page